MediPal MEPDF Stock
MediPal Price Chart
MediPal MEPDF Financial and Trading Overview
| MediPal stock price | 18.35 USD |
| Previous Close | 18.35 USD |
| Open | 18.35 USD |
| Bid | 16.38 USD x 10000 |
| Ask | 18.43 USD x 10000 |
| Day's Range | 18.35 - 18.35 USD |
| 52 Week Range | 15.9 - 19 USD |
| Volume | 1K USD |
| Avg. Volume | 17 USD |
| Market Cap | 3.76B USD |
| Beta (5Y Monthly) | -0.035 |
| PE Ratio (TTM) | 14.224807 |
| EPS (TTM) | 1.28 USD |
| Forward Dividend & Yield | 0.43 (2.35%) |
| Ex-Dividend Date | September 29, 2026 |
| 1y Target Est | N/A |
MEPDF Valuation Measures
| Enterprise Value | -142091780096 USD |
| Trailing P/E | 14.224807 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0009839853 |
| Price/Book (mrq) | 0.9230068 |
| Enterprise Value/Revenue | -0.037 |
| Enterprise Value/EBITDA | -1.746 |
Trading Information
MediPal Stock Price History
| Beta (5Y Monthly) | -0.035 |
| 52-Week Change | 12.92% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 19 USD |
| 52 Week Low | 15.9 USD |
| 50-Day Moving Average | 18.58 USD |
| 200-Day Moving Average | 17.63 USD |
MEPDF Share Statistics
| Avg. Volume (3 month) | 17 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 204.7M |
| Float | 178.38M |
| Short Ratio | N/A |
| % Held by Insiders | 8.54% |
| % Held by Institutions | 40.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 66 |
| Trailing Annual Dividend Yield | 359.67% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.3193 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 1.11% |
| Operating Margin (ttm) | 1.10% |
| Gross Margin | 6.83% |
| EBITDA Margin | 2.13% |
Management Effectiveness
| Return on Assets (ttm) | 1.77% |
| Return on Equity (ttm) | 6.84% |
Income Statement
| Revenue (ttm) | 3.82T USD |
| Revenue Per Share (ttm) | 18548.41 USD |
| Quarterly Revenue Growth (yoy) | 4.79% |
| Gross Profit (ttm) | 260.99B USD |
| EBITDA | 81.38B USD |
| Net Income Avi to Common (ttm) | 42.53B USD |
| Diluted EPS (ttm) | 1.29 |
| Quarterly Earnings Growth (yoy) | 26.70% |
Balance Sheet
| Total Cash (mrq) | 289.07B USD |
| Total Cash Per Share (mrq) | 1412.19 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.284 |
| Book Value Per Share (mrq) | 19.880678 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 46.55B USD |
| Levered Free Cash Flow (ttm) | 49.72B USD |
Profile of MediPal
| Country | United States |
| State | N/A |
| City | Tokyo |
| Address | 3-1-1 Kyobashi |
| ZIP | 104-8461 |
| Phone | 81 3 3517 5800 |
| Website | https://www.medipal.co.jp |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand; and distributes specialty pharmaceuticals. Further, the company is involved in contract logistics services; information provision services; health insurance claims review, medical coding dispatch, outsourcing and remote education; and creation of a medical supply database and master product databases for medical facilities. It serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fish producers, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Q&A For MediPal Stock
What is a current MEPDF stock price?
MediPal MEPDF stock price today per share is 18.35 USD.
How to purchase MediPal stock?
You can buy MEPDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MediPal?
The stock symbol or ticker of MediPal is MEPDF.
Which industry does the MediPal company belong to?
The MediPal industry is Medical Distribution.
How many shares does MediPal have in circulation?
The max supply of MediPal shares is 204.7M.
What is MediPal Price to Earnings Ratio (PE Ratio)?
MediPal PE Ratio is 14.33593800 now.
What was MediPal earnings per share over the trailing 12 months (TTM)?
MediPal EPS is 1.28 USD over the trailing 12 months.
Which sector does the MediPal company belong to?
The MediPal sector is Healthcare.


